EDGAR Filing Documents for 0001193125-13-432872

Form 8-K - Current report:

SEC Accession No. 0001193125-13-432872

Filing Date

2013-11-07

Accepted

2013-11-07 16:19:43

Documents

Period of Report

2013-11-07

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d626629d8k.htm	8-K	35226
2	EX-2.1	d626629dex21.htm	EX-2.1	489245
3	EX-2.2	d626629dex22.htm	EX-2.2	89972
4	EX-99.1	d626629dex991.htm	EX-99.1	131201
5	EX-99.2	d626629dex992.htm	EX-99.2	41232
6	GRAPHIC	g626629salix4c2line25.jpg	GRAPHIC	26135
7	GRAPHIC	g626629santarus1line.jpg	GRAPHIC	19891
	Complete submission text file	0001193125-13-432872.txt		851885

Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615

Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000

SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23265 | Film No.: 131200896
SIC: 2834 Pharmaceutical Preparations